Drugs / Changyanning Tablet
Changyanning Tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05687435 | Jan 2023 → Apr 2024 | irritable bowel syndrome | Mei Han | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Changyanning Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05687435 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese patent medicine Changyanning Tablet” NCT05687435 ↗ |
| Route | Oral | “is taken orally” NCT05687435 ↗ |